FORM FOR REFERRING WOMEN WITH BREAST CANCER FOR GENETICS ASSESSMENT

Slides:



Advertisements
Similar presentations
Every Womans Life PROGRAM MANUAL UPDATE
Advertisements

Sarcoma cancer patient pathways Why do sarcoma cancer patients breach cancer waiting time targets?
Kentucky Women’s Cancer Screening Program JULY 2013 CCSG CHANGES.
Princess Alexandra Hospitals NHS Trust Breast Unit Family History Clinic.
Hereditary Factors in Breast Cancer
Breast Cancer Risk and Risk Assessment Models
Breast cancer and medical second opinion
and confidential1 BREAST SERVICES IN GUILDFORD Julie Cooke Consultant Radiologist Jarvis Screening Centre and Royal Surrey.
SYNOPSIS OF THE PROTOCOL Title: Pregnancy Associated Breast Cancer (PABC); Prospective Data Registry in Saudi Arabia Sponsor: Oncology Department, King.
Breast cancer patient pathway
Overview of the hospital’s computer systems
Early Detection Is Your Best Protection. Breast Cancer Statistics for Women A woman has a one in eight chance of developing breast cancer in her lifetime.
Throckley Primary Care Results of Patient Information Survey
Information Advice Support Service. What is IASS: IASS deals with all telephone contacts and referrals for Children & Young People requiring information,
Shiva Sharma SHO to Professor Redmond.  Introduction  Increased risk groups  Consideration of genetic testing  Management of patients with mutation.
The Anticoagulation Service at Salisbury District Hospital Nic McQuaid And Rachel Woodford Anticoagulation Nurse Practitioners.
Gynaecology MDT Coordinator
Failure to appropriately screen women according to international guidelines– what are the consequences? Alison Johnston*, M Sugrue, S Curran Department.
Two week rule for breast
Other Performance Standards A&E:- A&E performance against the 4 hour standard improved in March and the Trust achieved 97.8%. Year to date overall performance.
Qualified Patient Criteria Combinations (Female and Male) Personal History of (any one of the below): Breast or Ovarian cancer (any age) Prostate or Pancreatic.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
Refer to Beds & Herts Breast Cancer Family History Screening service
Kristen Zarfos, MD Linda Steinmark, MS, LCGC
Paper Switch-off Programme Initial engagement
Referral Request and Referral Report
OUTPATIENT DIETETIC REFERRAL FORM
Having Breast Cancer Section 7.
The DEPression in Visual Impairment Trial:
OUTPATIENT DIETETIC REFERRAL FORM
BREAST CANCER ONCOLOGY NAVIGATION SERVICE
Coordination (benign lesions)
INSPIRED Interventions
Paper Switch-off Programme Initial engagement
Recognition and Referral of Suspected cancer NICE NG12 – 2Week Wait
‘ACHIEVING WORLD CLASS CANCER OUTCOMES’
Prevention and Early Diagnosis of Cancer Ongar Health Centre Patient Forum 7th March 2018 Sue White Cancer Research UK Facilitator.
WHY GENETIC COUNSELING IS IMPORTANT
Who in the room would offer BRCA1/2 testing to this patient Who in the room would offer BRCA1/2 testing to this patient? How might the medical management.
The Emergency Medical Treatment and Active Labor Act
How to refer a young carer to the Young Carers Project
Closing the Gap Hispanic Women and Breast Cancer
Refer to Beds & Herts Breast Cancer Family History Screening service
NHS ADULT SCREENING PROGRAMMES
Mastectomy and Reconstruction In Asian Breast Cancer Patients
Introduction and Survey Results
Neuro Oncology Therapy Update
National Academy Full Scholarship Application Form
Hannah Marder Cancer Manager UH Bristol
Inquiry into geographical inequalities in breast cancer
What is the role of genetic testing in patients with ovarian cancer?
Breast cancer pathway update – Primary care pathways event
Crisis Pregnancy Unwanted Pregnancy
General Imaging Information
NHS South Tees CCG Rapid Specialist Opinion (RSO)
The see and treat clinic
Assignment 2 Learning Aim D: Individual Treatment Plan
Having Breast Cancer Section 7.
Breast Multidisciplinary Team Meetings
Assignment 2 Learning Aim D: Individual Treatment Plan
Breast Cancer SSG 14th November
28 Day Faster Diagnosis Standard
SYNOPSIS OF THE PROTOCOL
HBOC Genetic counseling: major concerns and communication skills
PPG Meeting on general practice is changing
Ovarian cancer BRCA testing protocol
Breast Cancer BRCA testing protocol
Breast cancer BRCA testing protocol
MODERATE Risk 1 RISK FACTOR PRESENT Deformity OR Neuropathy OR Peripheral arterial disease No other risk factors x6 more likely to ulcerate Annual assessment.
MECS Peer Discussion.
Presentation transcript:

FORM FOR REFERRING WOMEN WITH BREAST CANCER FOR GENETICS ASSESSMENT August 2014 CJ FORM FOR REFERRING WOMEN WITH BREAST CANCER FOR GENETICS ASSESSMENT *NB. FAST TRACK referrals should only be made when outcome will impact on immediate treatment options and should be agreed with the on call cancer genetics consultant BEFORE referral is sent. Telephone: 020 7188 1364 Email: gst-tr.geneticsreferrals@nhs.net (for URGENT attn. on call cancer genetics consultant) Please indicate type of referral: Routine referral FAST TRACK referral* Guy’s Genetics Department referral criteria for women with breast cancer Refer any woman with 1) Breast cancer before age 30, 2) Triple negative breast cancer before age 50, 3) Breast cancer at any age and a family history of breast and/ or ovarian/ prostate cancer. Genetic testing may be offered to a woman with breast cancer if she meets the following criteria: Bilateral breast cancer (both cancers diagnosed <50 years) Breast and ovarian cancer Triple negative breast cancer diagnosed <50 years Bilateral breast cancer and a close relative with breast cancer <60 years Breast cancer <45 years and a relative with breast cancer <45 years Breast cancer and three or more relatives with breast or ovarian cancer Jewish or Polish ancestry and breast cancer <50 years Referring clinician: Sign: Print name: Title: Hospital: Contact number: Email address: Key worker: Date: (NB. Genetics clinician – for GSTT referrals include Key Worker & Breast Unit Manager in all correspondence.) Patient details: Telephone no: Full name: Age at diagnosis: Date of birth: Hospital number: Address: Date of diagnosis: NHS number: Family history: GP name, address and telephone no: Jewish ancestry/ ethnic origin: *For FAST TRACK REFERRALS ONLY Please answer all questions and continue overleaf if necessary What is the treatment plan (inc. timescales for chemo, planned date of surgery/radiotherapy etc.)? Can surgery be delayed if necessary? What is the histology and receptor status? (NB patient will not be accepted for fast track referral until the hormone receptor status is known unless she is eligible based on family history alone.) What impact will genetics assessment have on decision-making? Have possible surgical/ treatment implications of assessment been discussed with patient? (NB. Please refer as soon as possible after diagnosis in order for rapid testing to be considered)